Literature DB >> 8981472

Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein.

R D'Hooge1, G Nagels, C E Westland, L Mucke, P P De Deyn.   

Abstract

Cognitive and other behavioural characteristics of 3-month-old heterozygous male transgenic mice expressing the 751-amino acid isoform of human amyloid precursor protein (hAPP751) under the control of a neurone-specific enolase promoter, were compared with those of age-matched non-transgenic control males. No difference was found between hAPP751 transgenics and non-transgenic controls in passive avoidance learning, or in motor coordination. Significantly decreased measures were found in the open field test and in cage activity indicative of general hypoactivity in hAPP751 transgenics. In water maze training, hAPP751 males required significantly longer to locate the hidden platform. This was not due to decreased swimming velocity in hAPP751 mice, but rather to increased path lengths. This suggests a purely spatial learning deficit in hAPP751 males even though their performance during a final spatial test, the probe trail that followed water maze training, was indistinguishable from that of controls. Decreased activity and impaired spatial learning were also reported in an independent study of hAPP751-expressing transgenics showing beta-amyloid immunoreactive deposits and altered tau protein. Since such histopathological alterations were not found in the transgenic model analysed in this study, our results indicate that beta-amyloid deposition is not required for the development of behavioural and/or cognitive deficits in hAPP751 transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981472     DOI: 10.1097/00001756-199611040-00080

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

Authors:  H Meziane; J C Dodart; C Mathis; S Little; J Clemens; S M Paul; A Ungerer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

3.  Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Authors:  Debby Van Dam; Dorothee Abramowski; Matthias Staufenbiel; Peter Paul De Deyn
Journal:  Psychopharmacology (Berl)       Date:  2005-01-15       Impact factor: 4.530

Review 4.  Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?

Authors:  Andrew F Teich; Ottavio Arancio
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.

Authors:  Daniel Havas; Birgit Hutter-Paier; Kiren Ubhi; Edward Rockenstein; Karl Crailsheim; Eliezer Masliah; Manfred Windisch
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling.

Authors:  Ottavio V Vitolo; Antonino Sant'Angelo; Vincenzo Costanzo; Fortunato Battaglia; Ottavio Arancio; Michael Shelanski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

Review 8.  RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.

Authors:  Shirley ShiDu Yan; Doris Chen; Shiqian Yan; Lan Guo; Heng Du; John Xi Chen
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

9.  Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function.

Authors:  Charlotte Delay; Frédéric Calon; Paul Mathews; Sébastien S Hébert
Journal:  Mol Neurodegener       Date:  2011-10-07       Impact factor: 14.195

10.  Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening.

Authors:  Lei Chang; Lara Bakhos; Zhiqiang Wang; Duane L Venton; William L Klein
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.